In contrast, increased serum chemerin concentrations have been associated with more favorable clinical characteristics, such as reduced tumor size, differentiation, and stage and indicate the potential value of chemerin as a prognostic factor for disease-free survival [78,92]. Here, RARRES2 is linked to neoplasm.